p I 6"K4A, p I 5"K4B, and p i 8 proteins are highly specific inhibitors of cyclin-dependent serindthreonine kinase (CDK) activities required for G IS transition in the eukaryotic cell division cycle. Mutations, mainly homozygous deletions, of the CDKN2A (p16"K4A/MTSI) gene have been recently found i
Methylation status of the gene promoter of cyclin-dependent kinase inhibitor 2A ( CDKN2A ) in ovarian cancer
โ Scribed by Abou-Zeid, Abla A.; Azzam, Amal Z.; Kamel, Nahla A.
- Book ID
- 121396093
- Publisher
- Informa plc
- Year
- 2011
- Tongue
- English
- Weight
- 112 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0036-5513
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Defects in the system controlling the cell cycle can lead an increased proliferation of cancer cells. The aim of our study was to analyze the relationship between genetic changes leading to inactivation of the __CDKN2A__ gene and subsequent alteration of protein expression in squamous c
The status and the expression of cyclin-dependent kinase inhibitor A (CDKN2A) family genes, named CDKN2A, CDKN2B, and CDKN2C and of cyclin Ds (D1, D2, and D3) genes were investigated in 14 cases of human hepatoblastomas. These genes were selected because: 1) CDKN2A and CDKN2B are very frequently ina
Paraffin sections from 190 epithelial ovarian tumours, including 159 malignant and 31 benign epithelial tumours, were analysed immunohistochemically for expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16 INK4A (p16). Most benign tumours showed no p16 expression in the tumour
Cytogenetic deletions of the short arm of chromosome 9, 9p, have been detected in cell lines of malignant mesothelioma as well as in tumor material. Many tumor types carry deletions of chromosome 9 or more specifically of 9p21. The tumor-suppressor genes, CDKN2A and CDKN2B, each of which encodes a s